IMNM
Immunome Inc.
Key Financials
Operating Income
$-224113000
↑ 26.7%
Net Income
$-212394000
↑ 27.5%
Revenue
$6.9M
↓ 23.2%
EPS (Diluted)
$-2.43
↑ 51.4%
Total Assets
$683.2M
↑ 184.4%
Total Liabilities
$48.8M
↓ 17.3%
Shareholders' Equity
$634.3M
↑ 250.1%
Long-term Debt
$500000.00
N/A
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | IMNM |
| Company Name | Immunome Inc. |
| CIK | 1472012 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 610-321-3700 |